CN110419721A - 一种肿瘤专用型临床特殊营养配方及其制备方法 - Google Patents
一种肿瘤专用型临床特殊营养配方及其制备方法 Download PDFInfo
- Publication number
- CN110419721A CN110419721A CN201910774897.6A CN201910774897A CN110419721A CN 110419721 A CN110419721 A CN 110419721A CN 201910774897 A CN201910774897 A CN 201910774897A CN 110419721 A CN110419721 A CN 110419721A
- Authority
- CN
- China
- Prior art keywords
- parts
- tumour
- vitamin
- tailored version
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 67
- 235000005911 diet Nutrition 0.000 title claims abstract description 40
- 230000000378 dietary effect Effects 0.000 title claims abstract description 35
- 238000009472 formulation Methods 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000015097 nutrients Nutrition 0.000 claims abstract description 41
- 239000000284 extract Substances 0.000 claims abstract description 37
- 239000000203 mixture Substances 0.000 claims abstract description 33
- 235000016709 nutrition Nutrition 0.000 claims abstract description 33
- 241000233866 Fungi Species 0.000 claims abstract description 31
- 239000002131 composite material Substances 0.000 claims abstract description 30
- 229920000856 Amylose Polymers 0.000 claims abstract description 29
- 230000035764 nutrition Effects 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 23
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- 241000208340 Araliaceae Species 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 17
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 17
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 17
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 17
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 17
- 241000123107 Phellinus Species 0.000 claims abstract description 15
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 14
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 14
- 150000004676 glycans Chemical class 0.000 claims abstract description 11
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 11
- 239000005017 polysaccharide Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000011782 vitamin Substances 0.000 claims description 23
- 235000019197 fats Nutrition 0.000 claims description 22
- 150000001720 carbohydrates Chemical class 0.000 claims description 19
- 235000014633 carbohydrates Nutrition 0.000 claims description 19
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 18
- 235000010755 mineral Nutrition 0.000 claims description 18
- 239000011707 mineral Substances 0.000 claims description 18
- 235000018102 proteins Nutrition 0.000 claims description 18
- 229940088594 vitamin Drugs 0.000 claims description 18
- 229930003231 vitamin Natural products 0.000 claims description 18
- 235000013343 vitamin Nutrition 0.000 claims description 18
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 18
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 241000222684 Grifola Species 0.000 claims description 12
- 241000414067 Inonotus obliquus Species 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 12
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 10
- 235000013325 dietary fiber Nutrition 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- 244000017020 Ipomoea batatas Species 0.000 claims description 8
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 8
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 8
- 235000005822 corn Nutrition 0.000 claims description 8
- 235000013312 flour Nutrition 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 7
- 229930003471 Vitamin B2 Natural products 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 230000001376 precipitating effect Effects 0.000 claims description 7
- 229960002477 riboflavin Drugs 0.000 claims description 7
- 235000019164 vitamin B2 Nutrition 0.000 claims description 7
- 239000011716 vitamin B2 Substances 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- 102000015781 Dietary Proteins Human genes 0.000 claims description 6
- 108010010256 Dietary Proteins Proteins 0.000 claims description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 6
- 229930003448 Vitamin K Natural products 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229960003080 taurine Drugs 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 6
- 239000011719 vitamin A Substances 0.000 claims description 6
- 235000019168 vitamin K Nutrition 0.000 claims description 6
- 239000011712 vitamin K Substances 0.000 claims description 6
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 6
- 229940045997 vitamin a Drugs 0.000 claims description 6
- 229940046010 vitamin k Drugs 0.000 claims description 6
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 6
- 229960001763 zinc sulfate Drugs 0.000 claims description 6
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 claims description 5
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 5
- 102000011632 Caseins Human genes 0.000 claims description 5
- 108010076119 Caseins Proteins 0.000 claims description 5
- 102000004407 Lactalbumin Human genes 0.000 claims description 5
- 108090000942 Lactalbumin Proteins 0.000 claims description 5
- 235000019486 Sunflower oil Nutrition 0.000 claims description 5
- 229930003451 Vitamin B1 Natural products 0.000 claims description 5
- 229930003779 Vitamin B12 Natural products 0.000 claims description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 5
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 5
- 239000001506 calcium phosphate Substances 0.000 claims description 5
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 5
- 235000011010 calcium phosphates Nutrition 0.000 claims description 5
- 239000010495 camellia oil Substances 0.000 claims description 5
- 229940041514 candida albicans extract Drugs 0.000 claims description 5
- 239000005018 casein Substances 0.000 claims description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 5
- 235000021240 caseins Nutrition 0.000 claims description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 5
- 229960001231 choline Drugs 0.000 claims description 5
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 239000001103 potassium chloride Substances 0.000 claims description 5
- 235000011164 potassium chloride Nutrition 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- 239000011655 sodium selenate Substances 0.000 claims description 5
- 229960001881 sodium selenate Drugs 0.000 claims description 5
- 235000018716 sodium selenate Nutrition 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000002600 sunflower oil Substances 0.000 claims description 5
- 229960003495 thiamine Drugs 0.000 claims description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 5
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 235000010374 vitamin B1 Nutrition 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 239000012138 yeast extract Substances 0.000 claims description 5
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 4
- 102000014171 Milk Proteins Human genes 0.000 claims description 4
- 108010011756 Milk Proteins Proteins 0.000 claims description 4
- 235000005687 corn oil Nutrition 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- 235000021239 milk protein Nutrition 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 240000000950 Hippophae rhamnoides Species 0.000 claims 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims 1
- -1 Inonotue obliquus Substances 0.000 claims 1
- 101710094902 Legumin Proteins 0.000 claims 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 claims 1
- 239000013049 sediment Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 201000011510 cancer Diseases 0.000 abstract description 6
- 238000001959 radiotherapy Methods 0.000 abstract description 5
- 238000002512 chemotherapy Methods 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000004614 tumor growth Effects 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 235000013305 food Nutrition 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- 230000037213 diet Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 108010073771 Soybean Proteins Proteins 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000015380 nutritional deficiency disease Diseases 0.000 description 4
- 235000019710 soybean protein Nutrition 0.000 description 4
- 208000002720 Malnutrition Diseases 0.000 description 3
- 238000005265 energy consumption Methods 0.000 description 3
- 230000001071 malnutrition Effects 0.000 description 3
- 235000000824 malnutrition Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000004885 white matter Anatomy 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 229960001714 calcium phosphate Drugs 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000006545 glycolytic metabolism Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229960002816 potassium chloride Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 201000003102 mental depression Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/105—Sweet potatoes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
- A23L33/145—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供了一种肿瘤专用型临床特殊营养配方及其制备方法,营养配方为粉末状全营养配方,包括以下重量份组分:基础营养物50‑80份、营养强化剂0.1‑0.5份、中药提取物5‑10份、复合真菌多糖0.5‑5份,中药提取物为人参、枸杞、三七、葛根、冬虫夏草中药提取物混和粉末,复合真菌多糖包括桑黄多糖、白桦茸多糖、灰树花多糖,雷丸多糖和灵芝多糖。本发明包含人体所需的各种营养素,其高脂肪高蛋白低碳水化合物的组分结构,对肿瘤治疗过程中,有明显的抑制肿瘤生长的效果,中药提取物和复合真菌多糖对癌症肿瘤治疗中放疗、化疗后的病人具有调整人体功能、增强免疫力、提高人体气血效果和作用。
Description
技术领域
本发明涉及营养配方领域,具体涉及一种肿瘤专用型临床特殊营养配方及其制备方法。
背景技术
肿瘤是机体在各种致癌因素作用下,局部组织的某一个细胞在基因水平上失去对其生长的正常调控,导致其克隆性异常增生而形成的异常病变。由于肿瘤的消耗、自身代谢的紊乱、肿瘤对食欲的影响以及精神抑郁等因素,肿瘤患者伴随以体重下降为特征的营养不良发生率相当高,数据显示,我国40%~80%的肿瘤患者存在营养不良,而营养不良将会显著升高肿瘤并发症和死亡率。
肿瘤患者常存在营养不良是因为肿瘤患者的代谢与普通正常人有所不同,与正常人相比肿瘤病人的能量消耗会增加。能量消耗增加的原因有两个:一是肿瘤本身在细胞迅速分裂、肿瘤生长过程中需要大量的能量;二是肿瘤生长过程中产生的一些物质影响宿主的能量代谢,使病人能量消耗增加。仅使用常规食物无法满足病人对营养的需求,日常饮食营养不足的肿瘤病人应该选择特殊医学用途配方食品配合食用,从而改善病人的营养风险,促进病人康复。
特殊医学用途配方食品是指为了满足进食受限、消化吸收障碍、代谢紊乱或特定疾病状态人群对营养素或膳食的特殊需要,专门加工配制而成的配方食品。在营养支持产品中,全营养配方产品是可作为单一营养来源满足目标人群营养需求的特殊医学用途配方食品。肿瘤患者在摄入减少及代谢异常等情况下,特别是在化疗过程中出现摄入障碍时,为患者提供全营养配方产品,可以满足患者的能量需求,改善代谢,有助于维持肠粘膜细胞结构与功能的完整。
目前各种天然食物粉或营养素多存在以下问题:营养不全面,单独使用不能完全满足营养需求;产品多数为液体,不利于存储和运输;口味较为单调,不利于进食。同时,市面上缺少针对肿瘤患者,特别是对于放疗过程中的肿瘤患者食用的营养配方产品。
发明内容
本发明目的是为了弥补已有技术缺陷,提供一种肿瘤专用型临床特殊营养配方及其制备方法,适用于营养不良的肿瘤患者使用,尤其适用于手术、放疗、化疗治疗的晚期癌症患者使用
为实现上述目的,本发明通过以下方案予以实现:
本发明提供了一种肿瘤专用型临床特殊营养配方,营养配方为粉末状全营养配方,包括以下重量份组分:基础营养物50-80份、营养强化剂0.1-0.5份、中药提取物5-10份、复合真菌多糖0.5-5份,中药提取物为人参、枸杞、三七、葛根、冬虫夏草中药提取物混和粉末,复合真菌多糖包括桑黄多糖、白桦茸多糖、灰树花多糖、雷丸多糖和灵芝多糖。
优选地,基础营养物包括以下重量份组分:碳水化合物25-50份、脂肪5-10份、蛋白质15-40、膳食纤维5-8份、维生素0.5-2份、矿物质1-5份。
优选地,碳水化合物由红薯粉、玉米粉、燕麦粉和麦芽糊精精组成,各组分重量份为:红薯粉10-20份、玉米粉5-10份、燕麦粉5-10份、麦芽糊精5-15份。
优选地,脂肪为沙棘籽油、橄榄油、葵花籽油、玉米油、茶油中的一种或几种。
优选地,蛋白质为大豆蛋白、乳清蛋白、酪蛋白、牛奶蛋白中的一种或几种。
优选地,维生素为维生素C、维生素B1、维生素B2、维生素E、维生素A、维生素B12、维生素B6、维生素D3和维生素K中的一种或几种。
优选地,矿物质为括氯化钠、柠檬酸钠、碳酸钙、磷酸钙、氯化钾、碘化钾、硫酸锌和硒酸钠中的一种或几种。
优选地,营养强化剂为牛磺酸、左旋肉碱、胆碱、卵磷脂、酵母提取物中的一种或几种。
优选地,中药提取物各原料重量份为:人参2-5份、枸杞1-2份、三七1-2份、葛根1-2份、冬虫夏草0.5-1份。
优选地,复合真菌多糖各原料重量份为:桑黄0.1-1份、白桦茸0.1-0.8份、灰树花0.1-0.5份、雷丸0.2-1份、灵芝0.5-2份。
本发明还提供了一种肿瘤专用型临床特殊营养配方的制备方法,具体包括以下步骤:
(1)将人参、枸杞、三七、葛根、冬虫夏草洗净烘干后破碎至40-50目,加10-15倍重量量的纯水浸泡15-30min,再用水煎煮三次,合并三次煎煮药液,静置2h,取上清液,喷雾干燥后得中药提取物细粉;
(2)将桑黄、白桦茸、灰树花、雷丸、灵芝洗净烘干后破碎至100-120目,加10-15倍重量的纯水在温度60-80℃提取6-10小时,离心去沉淀后加入提取水重量60-85%的硫酸铵,搅拌后静置沉淀蛋白质,取上清液兑水透析后浓缩,加入3倍体积的95%乙醇,静置后离心沉淀,真空干燥得到复合真菌多糖;
(3)称量碳水化合物、脂肪、蛋白质、膳食纤维、维生素和矿物质,放入预混装置中预混20-30min,充分混合后得到基础营养物;
(4)向基础营养物中加入营养强化剂、中药提取物和复合真菌多糖,充分混合后的到肿瘤专用型临床特殊营养配方。
本发明的有益效果是:
(1)本发明营养配方粉中,包含人体所需的各种营养素,提供全营养支持,其高脂肪高蛋白低碳水化合物的组分结构,对肿瘤治疗过程中,有明显的抑制肿瘤生长的效果,因为在肿瘤供能过程中,癌细胞的酵解代谢需要大量的葡萄糖,但是不能利用脂肪,当食物中碳水化合物含量低时,就可以摧毁癌细胞酵解代谢的基础,同时高质量的蛋白质为身体提供了能量和生命必须的氨基酸,同时不会由此引起严重的血糖升高,摄取含丰富脂肪和蛋白质的食品,最终可实现在为健康细胞提供能量的同时,“消耗”掉侵略性的癌细胞;
(2)本发明营养配方粉中添加人参、枸杞、三七、葛根、冬虫夏草中药提取物混和粉末,人参中含有人参皂苷,有抑制肿瘤细胞生长、侵袭、转移的作用,同时人参具有大补元气、固脱生津之功,辅以枸杞、三七、葛根和冬虫夏草,对手术、放疗、化疗后正气虚弱之患者,有良好的恢复元气、提高免疫力的作用;
(3)本发明营养配方粉末中添加复合真菌多糖,真菌多糖可以刺激免疫活性,能增强网状内皮系统吞噬肿瘤细胞的作用,促进淋巴细胞转化,激活T细胞和B细胞,并促进抗体的形成。从而在一定程度上具有抗肿瘤的活性。
具体实施方式
下面将结合本发明实施例,对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。
实施例1
一种肿瘤专用型临床特殊营养配方,包括以下重量份组分:基础营养物55份、营养强化剂0.4份、中药提取物8份、复合真菌多糖5份。
基础营养物包括以下重量份组分:碳水化合物30份、脂肪8份、蛋白质25、膳食纤维6份、维生素0.8份、矿物质3份。
碳水化合物包括以下重量份组分:红薯粉15份、玉米粉6份、燕麦粉8份、麦芽糊精10份。
脂肪为沙棘籽油、葵花籽油和玉米油混合物。
蛋白质为大豆蛋白、乳清蛋白和酪蛋白混合物。
维生素为维生素C、维生素B1、维生素B2、维生素E、维生素A、维生素D3和维生素K的混合物。
矿物质为括氯化钠、柠檬酸钠、磷酸钙、碘化钾、硫酸锌和硒酸钠的混合物。
营养强化剂为牛磺酸、左旋肉碱、卵磷脂的混合物。
中药提取物各原料重量份为:人参5份、枸杞2份、三七1份、葛根2份、冬虫夏草0.5份。
复合真菌多糖各原料重量份为:桑黄0.5份、白桦茸0.8份、灰树花0.2份、雷丸0.8份、灵芝1份。
上述肿瘤专用型临床特殊营养配方的制备方法,具体包括以下步骤:
(3)将人参、枸杞、三七、葛根、冬虫夏草洗净烘干后破碎至50目,加10倍重量量的纯水浸泡20min,再用水煎煮三次,合并三次煎煮药液,静置2h,取上清液,喷雾干燥后得中药提取物细粉;
(4)将桑黄、白桦茸、灰树花、雷丸、灵芝洗净烘干后破碎至120目,加12倍重量的纯水在温度80℃提取8小时,离心去沉淀后加入提取水重量70%的硫酸铵,搅拌后静置沉淀蛋白质,取上清液兑水透析后浓缩,加入3倍体积的95%乙醇,静置后离心沉淀,真空干燥得到复合真菌多糖;
(3)称量碳水化合物、脂肪、蛋白质、膳食纤维、维生素和矿物质,放入预混装置中预混30min,充分混合后得到基础营养物;
(4)向基础营养物中加入营养强化剂、中药提取物和复合真菌多糖,充分混合后的到肿瘤专用型临床特殊营养配方。
实施例2
一种肿瘤专用型临床特殊营养配方,包括以下重量份组分:基础营养物65份、营养强化剂0.2份、中药提取物10份、复合真菌多糖2份。
基础营养物包括以下重量份组分:碳水化合物25份、脂肪10份、蛋白质30、膳食纤维8份、维生素1份、矿物质2份。
碳水化合物包括以下重量份组分:红薯粉20份、玉米粉10份、燕麦粉5份、麦芽糊精12份。
脂肪为葵花籽油、茶油的混合物。
蛋白质为乳清蛋白、酪蛋白和牛奶蛋白的混合物。
维生素为维生素C、维生素B1、维生素B2、维生素E、维生素A、维生素B6、和维生素K的混合物。
矿物质为括氯化钠、柠檬酸钠、碳酸钙、氯化钾、碘化钾和硫酸锌的混合物。
营养强化剂为牛磺酸、胆碱、酵母提取物的混合物。
中药提取物各原料重量份为:人参2份、枸杞1.5份、三七1份、葛根1份、冬虫夏草0.8份。
复合真菌多糖各原料重量份为:桑黄0.5份、白桦茸0.5份、灰树花0.2份、雷丸0.8份、灵芝1份。
上述肿瘤专用型临床特殊营养配方的制备方法,具体包括以下步骤:
(5)将人参、枸杞、三七、葛根、冬虫夏草洗净烘干后破碎至40目,加15倍重量量的纯水浸泡30min,再用水煎煮三次,合并三次煎煮药液,静置2h,取上清液,喷雾干燥后得中药提取物细粉;
(6)将桑黄、白桦茸、灰树花、雷丸、灵芝洗净烘干后破碎至100目,加10倍重量的纯水在温度70℃提取10小时,离心去沉淀后加入提取水重量60%的硫酸铵,搅拌后静置沉淀蛋白质,取上清液兑水透析后浓缩,加入3倍体积的95%乙醇,静置后离心沉淀,真空干燥得到复合真菌多糖;
(3)称量碳水化合物、脂肪、蛋白质、膳食纤维、维生素和矿物质,放入预混装置中预混30min,充分混合后得到基础营养物;
(4)向基础营养物中加入营养强化剂、中药提取物和复合真菌多糖,充分混合后的到肿瘤专用型临床特殊营养配方。
实施例3
一种肿瘤专用型临床特殊营养配方,包括以下重量份组分:基础营养物70份、营养强化剂0.5份、中药提取物8份、复合真菌多糖5份。
基础营养物包括以下重量份组分:碳水化合物40份、脂肪10份、蛋白质25、膳食纤维8份、维生素2份、矿物质5份。
碳水化合物包括以下重量份组分:红薯粉10份、玉米粉8份、燕麦粉5份、麦芽糊精10份。
脂肪为沙棘籽油、玉米油、茶油的混合物。
蛋白质为大豆蛋白,乳清蛋白,牛奶蛋白的混合物。
维生素为维生素C、维生素B2、维生素E、维生素A、维生素B12、维生素B6和维生素D3的混合物。
矿物质为括柠檬酸钠、磷酸钙、氯化钾、硫酸锌和硒酸钠的混合物。
营养强化剂为牛磺酸、胆碱和酵母提取物的混合物。
中药提取物各原料重量份为:人参3份、枸杞2份、三七2份、葛根1份、冬虫夏草1份。
复合真菌多糖各原料重量份为:桑黄1份、白桦茸0.8份、灰树花0.5份、雷丸1份、灵芝1.5份。
上述肿瘤专用型临床特殊营养配方的制备方法,具体包括以下步骤:
(7)将人参、枸杞、三七、葛根、冬虫夏草洗净烘干后破碎至45目,加10倍重量量的纯水浸泡15min,再用水煎煮三次,合并三次煎煮药液,静置2h,取上清液,喷雾干燥后得中药提取物细粉;
(8)将桑黄、白桦茸、灰树花、雷丸、灵芝洗净烘干后破碎至100目,加12倍重量的纯水在温度70℃提取8小时,离心去沉淀后加入提取水重量85%的硫酸铵,搅拌后静置沉淀蛋白质,取上清液兑水透析后浓缩,加入3倍体积的95%乙醇,静置后离心沉淀,真空干燥得到复合真菌多糖;
(3)称量碳水化合物、脂肪、蛋白质、膳食纤维、维生素和矿物质,放入预混装置中预混30min,充分混合后得到基础营养物;
(4)向基础营养物中加入营养强化剂、中药提取物和复合真菌多糖,充分混合后的到肿瘤专用型临床特殊营养配方。
实施例4
一种肿瘤专用型临床特殊营养配方,包括以下重量份组分:基础营养物60份、营养强化剂0.5份、中药提取物8份、复合真菌多糖5份。
基础营养物包括以下重量份组分:碳水化合物30份、脂肪10份、蛋白质20、膳食纤维5份、维生素0.8份、矿物质4份。
碳水化合物包括以下重量份组分:红薯粉15份、玉米粉8份、燕麦粉5份、麦芽糊精15份。
脂肪为沙棘籽油、葵花籽油、茶油的混合物。
蛋白质为大豆蛋白和酪蛋白的混合物。
维生素为维生素C、维生素B2、维生素E、维生素B12、维生素B6和维生素K的混合物。
矿物质为括磷酸钙、氯化钾、碘化钾、硫酸锌和硒酸钠的混合物。
营养强化剂为胆碱、卵磷脂、酵母提取物的混合物。
中药提取物各原料重量份为:人参5份、枸杞2份、三七1份、葛根1.5份、冬虫夏草0.5份。
复合真菌多糖各原料重量份为:桑黄0.5份、白桦茸0.8份、灰树花0.2份、雷丸1份、灵芝0.5份。
上述肿瘤专用型临床特殊营养配方的制备方法,具体包括以下步骤:
(9)将人参、枸杞、三七、葛根、冬虫夏草洗净烘干后破碎至40目,加15倍重量量的纯水浸泡30min,再用水煎煮三次,合并三次煎煮药液,静置2h,取上清液,喷雾干燥后得中药提取物细粉;
(10)将桑黄、白桦茸、灰树花、雷丸、灵芝洗净烘干后破碎至120目,加15倍重量的纯水在温度80℃提取10小时,离心去沉淀后加入提取水重量85%的硫酸铵,搅拌后静置沉淀蛋白质,取上清液兑水透析后浓缩,加入3倍体积的95%乙醇,静置后离心沉淀,真空干燥得到复合真菌多糖;
(3)称量碳水化合物、脂肪、蛋白质、膳食纤维、维生素和矿物质,放入预混装置中预混20min,充分混合后得到基础营养物;
(4)向基础营养物中加入营养强化剂、中药提取物和复合真菌多糖,充分混合后的到肿瘤专用型临床特殊营养配方。
临床试验
1、成分检测
选取实施例2制备的肿瘤专用型临床特殊营养配方作临床试验,首选对制得的营养配方成分进行检测,得到营养配方粉的主要营养成分如下表1所示:
表1肿瘤专用型临床特殊营养配方营养成分
项目 | 含量(每100g) | 项目 | 含量(每100g) | 项目 | 含量(每100g) |
热量/kJ | 1865 | 维生素C/mg | 182.5 | 钠/mg | 735 |
蛋白质/g | 22.4 | 维生素B1/mg | 1.35 | 钾/mg | 814 |
脂肪/g | 18.2 | 维生素B2/mg | 1.14 | 氯/mg | 648 |
饱和脂肪/g | 2.4 | 维生素B3/mg | 0.98 | 钙/mg | 514 |
反式脂肪酸/g | 0 | 维生素E/mg | 20.4 | 镁/mg | 201 |
糖/g | 3.7 | 维生素A/μg | 536.9 | 磷/mg | 417 |
膳食纤维/g | 4.8 | 维生素B12/μg | 4.2 | 铁/mg | 10.5 |
牛磺酸/mg | 76 | 维生素B6/mg | 1.33 | 锌/mg | 8.6 |
左旋肉碱/mg | 103 | 维生素D3/μg | 8.5 | 碘/μg | 39 |
卵磷脂/mg | 94 | 维生素K/μg | 43.9 | 硒/μg | 74 |
将其与《食品安全国家标准特殊医学用途配方食品通则》GB29922-2013规定的各项指标逐一对照,发现均符合要求。
2、研究对象
在医院门诊或病房选取肺癌患者100例,选择标准是:经过评估后可以自主进食的肺癌患者,其中57名男性及43名女性,患者平均年龄52.6±7.5岁,病程2.4±1.2年,按就诊顺序随机分为两组,分别为治疗组和对照组,每组50人。
3、治疗方案
治疗组患者通过常规放化疗手段治疗的同时使用实施例1中制备的肿瘤专用型临床特殊营养配方补充营养,早中晚各1次,每次食用300g,连续食用5周。对照组患者通过常规放化疗手段治疗并按照原有习惯日常进食,持续5周。
4、疗效标准
4.1、缓解率:经各种检查测量肿瘤,以其最大直径及最大垂直直径的乘积表示肿瘤治疗前后的变化和疗效,根据吸收程度可分为:①完全缓解(CR):肿瘤病灶完全消失;②部分缓解(PR):肿瘤病灶两径乘积缩小≥50%;③稳定(NR):肿瘤病灶两经乘积缩小<50%或增大<25%;④进展(PD):肿瘤病灶两经乘积增大≥25%。
4.2、免疫力评价。
5、治疗效果
治疗组和对照组疗效对比如表2-4所示:
表2治疗组和对照组疗效对比
表3治疗组和对照组免疫指标对比(X±S)
注:P值<0.01。
由表2和表3可知,本发明肿瘤专用型临床特殊营养配方对癌症肿瘤治疗中放疗、化疗后的病人具有调整人体功能,增强免疫力,提高人体气血,改善放化疗及服用其它消肿瘤药物后的反应,增强抗癌能力,对改善生存质量防止肿瘤的转移复发有很好的效果和作用。
在本说明书的描述中,参考术语“一个实施例”、“示例”、“具体示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不一定指的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任何的一个或多个实施例或示例中以合适的方式结合。
以上公开的本发明优选实施例只是用于帮助阐述本发明。优选实施例并没有详尽叙述所有的细节,也不限制该发明的具体实施方式。显然,根据本说明书的内容,可作很多的修改和变化。本说明书选取并具体描述这些实施例,是为了更好地解释本发明的原理和实际应用,从而使所属技术领域技术人员能很好地理解和利用本发明。本发明仅受权利要求书及其全部范围和等效物的限制。
Claims (10)
1.一种肿瘤专用型临床特殊营养配方,营养配方为粉末状全营养配方,包括以下重量份组分:基础营养物50-80份、营养强化剂0.1-0.5份、中药提取物5-10份、复合真菌多糖0.5-5份,所述基础营养物包括以下重量份组分:碳水化合物25-50份、脂肪5-10份、蛋白质15-40、膳食纤维5-8份、维生素0.5-2份、矿物质1-5份,所述中药提取物为人参、枸杞、三七、葛根、冬虫夏草中药提取物混和粉末,所述复合真菌多糖包括桑黄多糖、白桦茸多糖、灰树花多糖、雷丸多糖和灵芝多糖。
2.根据权利要求1所述的肿瘤专用型临床特殊营养配方,其特征在于,所述碳水化合物由红薯粉、玉米粉、燕麦粉和麦芽糊精精组成,各组分重量份为:红薯粉10-20份、玉米粉5-10份、燕麦粉5-10份、麦芽糊精5-15份。
3.根据权利要求1所述的肿瘤专用型临床特殊营养配方,其特征在于,所述脂肪为沙棘籽油、橄榄油、葵花籽油、玉米油、茶油中的一种或几种。
4.根据权利要求1所述的肿瘤专用型临床特殊营养配方,其特征在于,所述蛋白质为大豆蛋白、乳清蛋白、酪蛋白、牛奶蛋白中的一种或几种。
5.根据权利要求1所述的肿瘤专用型临床特殊营养配方,其特征在于,所述维生素为维生素C、维生素B1、维生素B2、维生素E、维生素A、维生素B12、维生素B6、维生素D3和维生素K中的一种或几种。
6.根据权利要求1所述的肿瘤专用型临床特殊营养配方,其特征在于,所述矿物质为括氯化钠、柠檬酸钠、碳酸钙、磷酸钙、氯化钾、碘化钾、硫酸锌和硒酸钠中的一种或几种。
7.根据权利要求1所述的肿瘤专用型临床特殊营养配方,其特征在于,所述营养强化剂为牛磺酸、左旋肉碱、胆碱、卵磷脂、酵母提取物中的一种或几种。
8.根据权利要求1所述的肿瘤专用型临床特殊营养配方,其特征在于,所述中药提取物各原料重量份为:人参2-5份、枸杞1-2份、三七1-2份、葛根1-2份、冬虫夏草0.5-1份。
9.根据权利要求1所述的肿瘤专用型临床特殊营养配方,其特征在于,所述复合真菌多糖各原料重量份为:桑黄0.1-1份、白桦茸0.1-0.8份、灰树花0.1-0.5份、雷丸0.2-1份、灵芝0.5-2份。
10.一种权利要求1-9任意一项所述的肿瘤专用型临床特殊营养配方的制备方法,其特征在于,包括以下步骤:
(1)将人参、枸杞、三七、葛根、冬虫夏草洗净烘干后破碎至40-50目,加10-15倍重量量的纯水浸泡15-30min,再用水煎煮三次,合并三次煎煮药液,静置2h,取上清液,喷雾干燥后得中药提取物细粉;
(2)将桑黄、白桦茸、灰树花、雷丸、灵芝洗净烘干后破碎至100-120目,加10-15倍重量的纯水在温度60-80℃提取6-10小时,离心去沉淀后加入提取水重量60-85%的硫酸铵,搅拌后静置沉淀蛋白质,取上清液兑水透析后浓缩,加入3倍体积的95%乙醇,静置后离心沉淀,真空干燥得到复合真菌多糖;
(3)称量碳水化合物、脂肪、蛋白质、膳食纤维、维生素和矿物质,放入预混装置中预混20-30min,充分混合后得到基础营养物;
(4)向基础营养物中加入营养强化剂、中药提取物和复合真菌多糖,充分混合后的到肿瘤专用型临床特殊营养配方。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910774897.6A CN110419721A (zh) | 2019-08-21 | 2019-08-21 | 一种肿瘤专用型临床特殊营养配方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910774897.6A CN110419721A (zh) | 2019-08-21 | 2019-08-21 | 一种肿瘤专用型临床特殊营养配方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110419721A true CN110419721A (zh) | 2019-11-08 |
Family
ID=68417149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910774897.6A Withdrawn CN110419721A (zh) | 2019-08-21 | 2019-08-21 | 一种肿瘤专用型临床特殊营养配方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110419721A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202000019789A1 (it) * | 2020-08-07 | 2022-02-07 | Kolinpharma S P A | Composizione multicomponente comprendente estratto di ganoderma lucidum, estratto di panax, vitamine, zinco e ceppi di batteri e suo uso nella prevenzione e nel trattamento dei sintomi influenzali e nell’aumento delle difese immunitarie |
-
2019
- 2019-08-21 CN CN201910774897.6A patent/CN110419721A/zh not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202000019789A1 (it) * | 2020-08-07 | 2022-02-07 | Kolinpharma S P A | Composizione multicomponente comprendente estratto di ganoderma lucidum, estratto di panax, vitamine, zinco e ceppi di batteri e suo uso nella prevenzione e nel trattamento dei sintomi influenzali e nell’aumento delle difese immunitarie |
WO2022029736A1 (en) * | 2020-08-07 | 2022-02-10 | Kolinpharma S.P.A. | Multi -component composition comprising ganoderma lucidum extract, panax extract, vitamins, zinc and bacterial strains and use thereof in the prevention and treatment of flu symptoms and in the increase in immune defences |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103330215A (zh) | 一种适用于肿瘤患者的营养配方食品 | |
CN108991500A (zh) | 一种肿瘤病人用全营养配方食品 | |
CN108013454A (zh) | 妇科炎症专用型临床营养配方及其制备方法 | |
CN105410932A (zh) | 一种肿瘤免疫型营养组合物及其应用 | |
CN109619552A (zh) | 适用于肿瘤患者的营养治疗型配方及制备方法、用途 | |
CN108391811A (zh) | 一种肿瘤全营养配方食品及其应用 | |
CN102755346A (zh) | 一种食用真菌复合多糖配方、制备方法及其应用 | |
CN107279978A (zh) | 一种适用于肿瘤病人的特殊医学用途配方食品 | |
CN111771988A (zh) | 适用于糖尿病人食用的营养食品及其制备方法 | |
CN105031301A (zh) | 一种抗肿瘤中药组合物及其制备方法 | |
CN104489681A (zh) | 一种具有增强免疫力功能的组合物、保健品及其制备方法 | |
CN101664180B (zh) | 一种具有保健功效的营养复合剂及其制备方法 | |
CN103155985B (zh) | 一种黄精营养粉及其制备方法 | |
CN110419721A (zh) | 一种肿瘤专用型临床特殊营养配方及其制备方法 | |
CN102813199A (zh) | 一种预防及辅助治疗癌症、三高症及增强免疫力的保健食品 | |
CN105433382B (zh) | 一种玛咖组合物及其制备方法和用途 | |
CN106360742A (zh) | 一种用于肥胖或减脂手术患者的营养食品组合物 | |
CN102784163A (zh) | 一种食用菌类复合多糖养生保健治疗配方及其制备方法 | |
CN102228181B (zh) | 一种供癌症患者食用含低聚肽和壳寡糖的组合物 | |
CN108142936A (zh) | 一种用于肿瘤患者的海洋生物型特殊医学用途配方食品 | |
CN101524153A (zh) | 益于糖尿病人的保健小麦面粉 | |
CN114868890A (zh) | 一种适用肿瘤患者多维营养素配方 | |
CN103622027A (zh) | 一种降血糖保健食品组合物 | |
CN107136490A (zh) | 一种肽虫草保健品 | |
CN102784230A (zh) | 一种治疗营养性贫血的药物组合物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20191108 |
|
WW01 | Invention patent application withdrawn after publication |